Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Guideline

KASL clinical practice guidelines for management of chronic hepatitis B

Clin Mol Hepatol. 2022;28(2):276-331. Published online April 1, 2022

DOI: https://doi.org/10.3350/cmh.2022.0084 Correction in: Clin Mol Hepatol 2022;28(4):940

View: 10341 Download: 587 Web of Science: 35 Crossref: 43

Review

Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease

Karn Wijarnpreecha, Elizabeth S. Aby, Aijaz Ahmed, Donghee Kim

Clin Mol Hepatol. 2021;27(2):221-235. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0239

View: 7826 Download: 352 Web of Science: 26 Crossref: 29

3

Durability of a sustained virologic response in combination therapy with interferon/peginterferon and ribavirin for chronic hepatitis C

Chul Hyun Kim , Byung Do Park , Jin Woo Lee , Young Soo Kim , Seok Jeong , Don Haeng Lee , Hyung Gil Kim , Yong Woon Shin , Key Sook Kwon , Jung Il Lee

Clin Mol Hepatol. 2009;15(1):70-79. Published online March 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.1.70

View: 4430 Download: 23 Crossref: 9

Surgical Treatment of Sclerosing Hepatocellular Carcinoma

Bum-Soo Kim, M.D., Sung-Gyu Lee, M.D., Shin Hwang, M.D., Young-Joo Lee, M.D., Kwang-Min Park, M.D., Ki-Hun Kim, M.D., Chul-Soo Ahn, M.D., Deok-Bog Moon, M.D., Tae-Yong Ha, M.D., Gi-Won Song, M.D., Dong-Hwan Jung, M.D., and Ki-Myung Moon, M.D.

Clin Mol Hepatol. 2006;12(3):412-419. Published online January 1, 2000

View: 2795 Download: 23

2

Primary Biliary Cirrhosis

Chae Yoon Chon , Jun Yong Park

Clin Mol Hepatol. 2006;12(3):364-372. Published online January 1, 2000

View: 3111 Download: 34

4

A Case of Infiltrative Hepatocellular Carcinoma with Main Portal Vein Tumor Thrombosis Successfully Treated by Transarterial Chemoembolization

Sun-Jung Myung, M.D., Jung-Hwan Yoon, M.D., Geum-Youn Gwak, M.D., Cheol Min Shin, M.D., Dong Won Ahn, M.D., Su Jong Yu, M.D., Ji-Won Yu, M.D., Soo-Jeong Cho, M.D., Jin Wook Chung, M.D. and Hyo-Suk Lee, M.D.

Clin Mol Hepatol. 2006;12(1):107-111. Published online January 1, 1970

View: 2893 Download: 22

3

Clinical Experience of 48 Acute Toxic Hepatitis Patients

Jeong Chul Seo, M.D., Won Joong Jeon, M.D., Sung Soon Park, M.D., Seok Hyung Kim, M.D. Ki Man Lee, M.D., Hee Bok Chae, M.D., Seon Mee Park, M.D. and Sei Jin Youn, M.D.

Clin Mol Hepatol. 2006;12(1):74-81. Published online January 1, 1970

View: 3449 Download: 51

Peginterferon Alfa-2a plus Ribavirin for Initial Treatment of Chronic Hepatitis C in Korea

Hyuk Lee, M.D., Moon Seok Choi, M.D., Seung Woon Paik, M.D., Jeong Hwan Kim, M.D., Do Young Kim, M.D., Joon Hyoek Lee, M.D., Kwang Cheol Koh, M.D., Byung Chul Yoo, M.D., Jong Chul Rhee, M.D. and Soon Mi Song, R.N.

Clin Mol Hepatol. 2006;12(1):31-40. Published online January 1, 1970

View: 3111 Download: 18

1 |

Viewed By 5378	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5336	MAFLD: How is it different from NAFLD?
Viewed By 5226	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3904	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3870	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search